Dr. Ann M. Maguire, MD

Dr. Maguire practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Maguire's NPI, 1689626426, was assigned on May 17, 2006. Dr. Maguire graduated from Perelman School of Med at the University of Pennsylvania in 1990. Dr. Maguire holds Wisconsin license 39910.

Dr. Maguire's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Maguire's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Maguire is also affiliated with Froedtert Menomonee Falls Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Maguire to 1 more hospital, 2 home health agencies, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maguire practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Maguire's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Maguire is licensed in Wisconsin.

CMS data shows 761 Medicare services from Dr. Maguire across 4 procedure codes in 2024, for 318 Medicare patients. Medicare paid $51,656 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 318 Medicare patients who saw Dr. Maguire in 2024. The largest group is 65 to 74, with 169 patients. 71% of them have high cholesterol, and 66% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Maguire's median patient age at 63, with 70% women.

In 2024, Dr. Maguire wrote 10,137 Medicare Part D claims for 751 patients. 88% of them were for generic drugs. CMS names the drug for 9,319 of them, across 125 drugs with 11 or more claims each, at $612,481 in total drug cost. In 2023, CMS named 9,127 claims across 129 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Maguire for performance year 2024, reported as part of a group. Dr. Maguire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maguire as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Maguire, published from 2015 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Australia, Cancer Survivors and Adrenal Insufficiency. Dr. Maguire has published most often in Clin Endocrinol (Oxf). Dr. Maguire's most frequent co-authors are Yoon Cho, MD, Brian Carl Hilgeman, MD and Martin D. Muntz, MD.

Dmand AI links Dr. Maguire to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus.

CMS Open Payments shows 15 general payments to Dr. Maguire from 2 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 60% of the total. Exact Sciences Corporation paid the most, $268.

Dr. Maguire graduated from Perelman School of Med at the University of Pennsylvania in 1990.